Patrick Yves Toullec et al.
FULL PAPERS
were 21.7 and 24.9 min; [a]D À7.3 (CHCl3, c 0.45) at 95%
ee.
(m, 9H); 13C NMR (75 MHz, CDCl3): d=10.8, 29.5, 39.6,
41.8, 45.1, 48.2, 52.6, 52.7, 57.9, 108.7, 109.4, 113.7, 119.0,
119.4, 120.3, 125.7, 126.6, 128.1, 128.2, 133.1, 136.7, 145.0,
150.2, 172.2, 172.3; CI-MS (NH3): m/z=432 [M+H]+; HR-
MS: m/z=432.2177, calcd. for C27H30O4N: 432.2175. The
product ratio was determined by HPLC using a Chiralcel
AS-H (hexane/2-propanol: 98/2, 1 mLminÀ1). The retention
times for the two enantiomers were 12.3 and 14.7 min; [a]D:
À8.9 (CHCl3, c 1.02) at 89% ee.
Diisopropyl 3-[1-(1-methyl-1H-indol-3-yl)-phenylmethyl]-
4-methylenecyclopentane-1,1-dicarboxylate (2b): TLC (pe-
troleum ether/ethyl acetate: 95/5): Rf =0.13; 1H NMR
(300 MHz, CDCl3): d=1.21 (d, J=6.3 Hz, 3H), 1.17–1.23
(m, 9H), 1.94 (dd, J=13.6, 8.6 Hz, 1H), 2.73 (dd, J=13.6,
7.8 Hz, 1H), 2.87 (d, J=16.0 Hz, 1H), 3.11 (dq, J=15.9,
1.9 Hz, 1H), 3.50–3.58 (m, 1H), 3.76 (s, 3H), 4.12 (s, 1H),
4.16 (d, J=10.5 Hz, 1H), 4.78 (s, 1H), 4.97 (hept, J=6.3 Hz,
1H), 5.06 (hept, J=6.3 Hz, 1H), 7.00–7.35 (m, 8H), 7.56 (d,
J=8.0 Hz, 1H); 13C NMR (75 MHz, CDCl3): d=21.5, 32.7,
39.7, 41.7, 46.9, 48.0, 58.5, 68.7, 68.9, 109.1, 109.6, 117.3,
118.8, 119.5, 121.5, 125.9, 126.2, 127.6, 128.0, 128.4, 136.9,
144.7, 149.4, 171.2, 171.4; CI-MS (NH3): m/z=474 [M+H]+;
HR-MS (CI-CH4): m/z=474.2633, calcd. for C30H36O4N:
474.2644. The product ratio was determined by HPLC using
a Chiralcel AD-H (hexane/2-propanol: 98/2, 1 mLminÀ1).
The retention times for the two enantiomers were 10.6 and
11.2 min; [a]D: À9.7 (CHCl3, c 0.48) at 82% ee.
Dimethyl 3-[1-(1-methyl-2-phenyl-1H-indol-3-yl)-phenyl-
methyl]-4-methylenecyclopentane-1,1-dicarboxylate
(2f):
1
TLC (cyclohexane/ethyl acetate: 80/20): Rf =0.45; H NMR
(300 MHz, CDCl3): d=1.90 (dd, J=13.8, 9.3 Hz, 1H), 2.57
(dd, J=13.8, 9.3 Hz, 1H), 2.99 (s, 2H), 3.49 (s, 3H), 3.68 (s,
3H), 3.76 (s, 3H), 3.90–4.00 (m, 1H), 4.12 (s, 1H), 4.72 (s,
1H), 7.05–7.97 (m, 14H); 13C NMR (75 MHz, CDCl3): d=
30.7, 40.0, 41.7, 45.0, 48.1, 52.6, 52.7, 57.9, 109.3, 109.4, 115.4,
119.5, 120.5, 121.4, 125.7, 126.3, 127.9, 128.2, 128.4, 131.2,
132.2, 137.2, 138.5, 144.9, 149.8, 172.2, 172.3; CI-MS (NH3):
m/z=494 [M+H]+; HR-MS: m/z=494.2327, calcd. for
C32H32O4N: 494.2331. The product ratio was determined by
HPLC using a Chiralcel OD-H (hexane/2-propanol: 99/1,
1 mLminÀ1). The retention times for the two enantiomers
were 10.4 and 11.7 min; [a]D: +35.0 (CHCl3, c 0.68) at 74%
ee.
Dibenzyl 3-[1-(1-methyl-1H-indol-3-yl)-phenylmethyl]-4-
methylenecyclopentane-1,1-dicarboxylate (2c): TLC (petro-
leum ether/ethyl acetate: 95/5): Rf =0.08; 1H NMR
(300 MHz, CDCl3): d=2.03 (dd, J=13.2, 8.0 Hz, 1H), 2.78
(dd, J=13.6, 7.9 Hz, 1H), 2.95 (d, J=15.8 Hz, 1H), 3.16 (dd,
J=16.0, 1.9 Hz, 1H), 3.48–3.57 (m, 1H), 3.72 (s, 3H), 4.14–
4.17 (m, 2H), 4.78 (s, 1H), 4.99 (d, J=12.3 Hz, 1H), 5.10 (d,
J=12.3 Hz, 1H), 5.12 (s, 2H), 6.94 (s, 1H), 7.01–7.32 (m,
13H), 7.53 (d, J=7.9 Hz, 1H); 13C NMR (75 MHz, CDCl3):
d=32.7, 39.8, 41.8, 47.9, 58.6, 67.2, 109.1, 110.0, 117.1, 118.9,
119.4, 121.5, 126.0, 126.1, 127.6, 127.9, 128.0, 128.1, 128.2,
128.4, 135.4, 135.5, 136.9, 144.6, 148.9, 171.4, 171.5; CI-MS
(NH3): m/z=587 [M+NH4]+, 570 [M+H]+; HR-MS (CI-
CH4): m/z=570.2645, calcd. for C38H36O4N: 570.2644. The
product ratio was determined by HPLC using a Chiralcel
OD-H (hexane/2-propanol: 98/2, 1 mLminÀ1). The retention
times for the two enantiomers were 36.4 and 53.9 min; [a]D:
À3.2 (CHCl3, c 0.50) at 83% ee.
Dimethyl 3-[1-(1-methyl-5-methoxy-1H-indol-3-yl)-phe-
nylmethyl]-4-methylenecyclopentane-1,1-dicarboxylate (2g):
1
TLC (cyclohexane/ethyl acetate: 80/20): Rf =0.27; H NMR
(300 MHz, CDCl3): d =1.88 (dd, J=13.6, 8.5 Hz, 1H), 2.68
(ddd, J=13.6, 7.9, 1.5 Hz, 1H), 2.80 (dd, J=15.8, 1.0 Hz,
1H), 3.03 (dq, J=15.8, 2.5 Hz, 1H), 3.36–3.43 (m, 1H), 3.56
(s, 3H), 3.64 (s, 6H), 3.72 (s, 3H), 3.99 (d, J=10.3 Hz, 1H),
4.03 (s, 1H), 4.71 (s, 1H), 6.75 (dd, J=8.9, 2.3 Hz, 1H),
6.87–6.89 (m, 2H), 7.00–7.25 (m, 6H); 13C NMR (75 MHz,
CDCl3): d=32.9, 39.9, 41.8, 46.8, 48.1, 52.6, 52.7, 55.9, 58.4,
101.6, 109.8, 109.9, 111.6, 116.6, 126.0, 126.8, 127.9, 128.1,
128.4, 132.3, 144.6, 149.0, 153.6, 172.1, 172.3; CI-MS (NH3):
m/z=448 [M+H]+; HR-MS (CI-NH3): m/z=448.2133,
calcd. for C27H30O5N [M+H]+: 448.2124. The product ratio
was determined by HPLC using a Chiralcel AD-H (hexane/
2-propanol: 90/10, 1 mLminÀ1). The retention times for the
two enantiomers were 12.5 and 14.6 min; [a]D: À19.5
(CHCl3, c 0.48) at 87% ee.
Di-tert-butyl 3-[1-(1-methyl-1H-indol-3-yl)-phenylmeth-
yl]-4-methylenecyclopentane-1,1-dicarboxylate (2d): TLC
(petroleum ether/ethyl acetate: 95/5): Rf =0.25; 1H NMR
(300 MHz, CDCl3): d=1. 29 (s, 9H), 1.35 (s, 9H), 1.76 (dd,
J=13.6, 8.7 Hz, 1H), 2.55 (ddd, J=13.6, 7.9, 1.5 Hz, 1H),
2.68 (dd, J=15.6, 1.3 Hz, 1H), 2.92 (dq, J=15.8, 2.5 Hz,
1H), 3.37–3.46 (m, 1H), 3.65 (s, 3H), 3.98 (s, 1H), 4.04 (d,
J=10.4 Hz, 1H), 4.66 (s, 1H), 6.89–7.15 (m, 7H), 7.21–7.25
(m, 2H), 7.44 (d, J=7.9 Hz, 1H); 13C NMR (75 MHz,
CDCl3): d=27.9, 32.7, 39.7, 41.8, 46.7, 48.2, 59.7, 81.0, 81.3,
109.0, 109.4, 117.3, 118.7, 119.6, 121.4, 125.9, 126.2, 127.7,
128.0, 128.5, 137.0, 144.8, 149.6, 171.0, 171.2; CI-MS (NH3):
m/z=502 [M+H]+, 446 [MÀC4H8 +H]+: HR-MS (CI-CH4):
m/z=501.2871, calcd. for C32H39O4N: 501.2879. The product
ratio was determined by HPLC using a Chiralcel OD-H
(hexane/2-propanol: 99/1, 1 mLminÀ1). The retention times
for the two enantiomers were 10.0 and 11.7 min; [a]D: À14.8
(CHCl3, c 0.54) at 80% ee.
Dimethyl
3-[1-(2,4-dimethoxyphenyl)-phenylmethyl]-4-
methylenecyclopentane-1,1-dicarboxylate (2h): H, 13C NMR
and mass spectroscopy data for compound 2h were identical
to literature values.[2] The product ratio was determined by
HPLC using a Chiralcel AS-H (hexane/2-propanol: 98/2,
1 mLminÀ1). The retention times for the two enantiomers
were 11.1 and 12.6 min; [a]D: +26.6 (CHCl3, c 1.58) at 80%
ee.
1
Dimethyl 3-[1-(2,4,6-trimethoxyphenyl)-phenylmethyl]-4-
1
methylenecyclopentane-1,1-dicarboxylate (2i): H, 13C NMR
and mass spectroscopy data for compound 2i were identical
to literature values.[2] Product ratio was determined by
HPLC using a Chiralcel AS-H (hexane/2-propanol: 98/2,
1 mLminÀ1). The retention times for the two enantiomers
were 11.8 and 12.8 min; [a]D: + 92.1 (CHCl3, c 2.9) at 77%
ee.
Dimethyl 3-[1-(1-methyl-1H-indol-3-yl)-(3,4-methylene-
dioxy)phenylmethyl]-4-methylenecyclopentane-1,1-dicarbox-
ylate (2j): TLC (cyclohexane/ethyl acetate: 80/20): Rf =0.35;
Dimethyl 3-[1-(1-methyl-2-methyl-1H-indol-3-yl)-phenyl-
methyl]-4-methylenecyclopentane-1,1-dicarboxylate
(2e):
1
TLC (cyclohexane/ethyl acetate: 80/20): Rf =0.50; H NMR
(300 MHz, CDCl3): d=1.70–1.90 (m, 1H), 2.45 (s, 3H),
2.50–2.60 (m, 1H), 3.62 (s, 3H), 3.65 (s, 3H), 3.75 (s, 3H),
3.80–4.20 (m, 2H), 4.30 (br s, 1H), 4.70 (br s, 1H), 6.90–7.80
2406
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2008, 350, 2401 – 2408